Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Dae Suk Han"'
Autor:
Hyung Woo Kim, Geun Woo Ryu, Cheol Ho Park, Ea Wha Kang, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo, Sug Kyun Shin, Shin-Wook Kang, Kyu Hun Choi, Dae Suk Han, Tae Ik Chang
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129480 (2015)
Cardiovascular (CV) disease is the leading cause of morbidity and mortality in patients on peritoneal dialysis (PD). Hyponatremia was recently shown to be a modifiable factor that is strongly associated with increased mortality in PD patients. Howeve
Externí odkaz:
https://doaj.org/article/aa6347f271af4199bb3ff580e1d7756d
Autor:
Tae Ik Chang, Yung Ly Kim, Hyungwoo Kim, Geun Woo Ryu, Ea Wha Kang, Jung Tak Park, Tae-Hyun Yoo, Sug Kyun Shin, Shin-Wook Kang, Kyu Hun Choi, Dae Suk Han, Seung Hyeok Han
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e111373 (2014)
Background and aimHyponatremia is common in patients with chronic kidney disease and is associated with increased mortality in hemodialysis patients. However, few studies have addressed this issue in peritoneal dialysis (PD) patients.MethodsThis pros
Externí odkaz:
https://doaj.org/article/40dd922e12e645fb92fb144bbeb6107f
Autor:
Tae Ik Chang, Hyung Jung Oh, Ea Wha Kang, Tae-Hyun Yoo, Sug Kyun Shin, Shin-Wook Kang, Kyu Hun Choi, Dae Suk Han, Seung Hyeok Han
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82912 (2013)
BACKGROUND AND AIM: Metabolic acidosis is common in patients with chronic kidney disease and is associated with increased mortality in hemodialysis patients. However, this relationship has not yet been determined in peritoneal dialysis (PD) patients.
Externí odkaz:
https://doaj.org/article/65072b4942894db0876632a1dd0c8127
Autor:
Tae Hyun Yoo, Mi Jung Lee, Hyung Jung Oh, Dae Suk Han, Seung Hyeok Han, Jung Tak Park, Shin Wook Kang
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 35:366-369
Autor:
Hyang Sook Yoon, Ea Wha Kang, Tae Hyun Yoo, Kyu Hun Choi, Sang Choel Lee, Seung Hyeok Han, Shin Wook Kang, Dae Suk Han, Jung Kyung Park
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 32:149-158
♦Background Endothelial dysfunction, which contributes to atherosclerosis and arteriosclerosis, commonly accompanies end-stage renal disease (ESRD). However, little is known about the role of residual renal function (RRF) in endothelial protection
Autor:
Dae Suk Han, Seung Hyeok Han
Publikováno v:
Nature Reviews Nephrology. 8:163-175
Protein-energy wasting (PEW) is prevalent among patients on dialysis and has emerged as an important risk factor for morbidity and mortality in these patients. Numerous factors, including inflammation, inadequate dialysis, insufficient nutrient intak
Autor:
Kyu Hun Choi, Shin Wook Kang, Tae Hyun Yoo, Dong Ho Shin, Dae Suk Han, Dong Eun Yoo, Seung Hyeok Han, Seung Jun Kim, Mi Jung Lee, Hyung Jung Oh
Publikováno v:
Endocrine Journal. 59:685-695
In patients with end-stage renal disease (ESRD), circulating adipokine levels are increased due to decreased renal clearance, irrespective of obesity. However, whether adipokines play a role in the development of insulin resistance (IR) in non-obese
Publikováno v:
Automation in Construction. 20:368-379
The aim of this study is to establish a procedure for systematic design and performance evaluation of an offshore platform (FPSO; Floating, Production, Storage and Offloading) crane using a computational approach. Coupling analyses of the finite elem
Autor:
Seung Hyeok Han, Tae Hyun Yoo, Jeong Hae Kie, Kyu Hun Choi, Dae Suk Han, Shin Wook Kang, Ea Wha Kang
Publikováno v:
American Journal of Kidney Diseases. 56:1163-1167
Although most cases of immunoglobulin A (IgA) nephropathy are idiopathic, several diseases are associated with IgA nephropathy. Of these, chronic liver disease resulting from hepatitis B or C virus infection has been reported as a secondary cause of
Autor:
Hak Chul Jang, Sung Hee Choi, Young Joo Park, Seung Hyeok Han, Kyong Soo Park, Dae Suk Han, Min Kyung Moon, Hong Kyu Lee, Shin Wook Kang, Yenna Lee, Bong Jun Cho, Soo Lim, Young-Bum Kim
Publikováno v:
Metabolism. 59:1656-1662
Fibroblast growth factor-21 (FGF-21) is a new metabolic regulator, which is related to antiobesity and insulin sensitivity in vivo. However, the clinical implication of FGF-21 is poorly understood. To investigate whether FGF-21 may play a role as a m